{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T17:12:51Z","timestamp":1765041171220,"version":"build-2065373602"},"reference-count":25,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T00:00:00Z","timestamp":1620000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: COVID-19 pandemic severely impacted public health services worldwide, determining a significant decrease of elective cardiovascular (CV) procedures, especially in patients with associated chronic diseases such as diabetes mellitus (DM). Materials and Methods: This study was first started in 2019 in the western of Romania, to analyze the differences regarding the implantations of intra-cardiac devices such as permanent pacemakers (PPM), cardiac resynchronization therapy (CRT), or implantable cardioverter-defibrillators (ICD) in 351 patients with and without DM and the situation was reanalyzed at the end of 2020. Results: of the first 351 patients with and without DM. 28.20% of these patients had type 2 DM (p = 0.022), exceeding more than twice the prevalence of DM in the general population (11%). Patients with DM were younger (p = 0.022) and required twice as often CRT (p = 0.002) as non-diabetic patients. The state of these procedures was reanalyzed at the end of 2020, a dramatic decrease of all new device implantations being observed, both in non-diabetic and in patients with type 2 DM (79.37%, respectively 81.82%). Conclusions: COVID-19 pandemic determined a drastic decrease, with around 75% reduction of all procedures of new intra-cardiac devices implantation, both in non-diabetics, this activity being reserved mostly for emergencies.<\/jats:p>","DOI":"10.3390\/medicina57050441","type":"journal-article","created":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T22:51:42Z","timestamp":1620255102000},"page":"441","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Impact of COVID-19 Pandemic on the Implantation of Intra-Cardiac Devices in Diabetic and Non-Diabetic Patients in the Western of Romania"],"prefix":"10.3390","volume":"57","author":[{"given":"Silvius Alexandru","family":"Pescariu","sequence":"first","affiliation":[{"name":"Department VI, Cardiology, University of Medicine and Pharmacy \u201cVictor Babes\u201d Timisoara, E. Murgu Square, Nr. 2, 300041 Timisoara, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7351-741X","authenticated-orcid":false,"given":"Cristina","family":"Tudoran","sequence":"additional","affiliation":[{"name":"Department VII, Internal Medicine II, Discipline of Cardiology, University of Medicine and Pharmacy \u201cVictor Babes\u201d Timisoara, E. Murgu Square, Nr. 2, 300041 Timisoara, Romania"},{"name":"County Emergency Hospital, 300041 Timisoara, Romania"},{"name":"Center of Molecular Research in Nephrology and Vascular Disease, Faculty of Medicine, University of Medicine and Pharmacy \u201cVictor Babes\u201d Timisoara, E. Murgu Square, Nr. 2, 300041 Timisoara, Romania"},{"name":"County Emergency Hospital \u201cPius Brinzeu\u201d, L. Rebreanu Str., Nr. 156, 300041 Timisoara, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9947-8316","authenticated-orcid":false,"given":"Gheorghe Nicusor","family":"Pop","sequence":"additional","affiliation":[{"name":"Department VI, Cardiology, University of Medicine and Pharmacy \u201cVictor Babes\u201d Timisoara, E. Murgu Square, Nr. 2, 300041 Timisoara, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sorin","family":"Pescariu","sequence":"additional","affiliation":[{"name":"Department VI, Cardiology, University of Medicine and Pharmacy \u201cVictor Babes\u201d Timisoara, E. Murgu Square, Nr. 2, 300041 Timisoara, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romulus Zorin","family":"Timar","sequence":"additional","affiliation":[{"name":"Center of Molecular Research in Nephrology and Vascular Disease, Faculty of Medicine, University of Medicine and Pharmacy \u201cVictor Babes\u201d Timisoara, E. Murgu Square, Nr. 2, 300041 Timisoara, Romania"},{"name":"County Emergency Hospital \u201cPius Brinzeu\u201d, L. Rebreanu Str., Nr. 156, 300041 Timisoara, Romania"},{"name":"Department VII, Internal Medicine II, Division of Diabetes and Matabolic Diseases, University of Medicine and Pharmacy \u201cVictor Babes\u201d Timisoara, E. Murgu Square, Nr. 2, 300041 Timisoara, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana","family":"Tudoran","sequence":"additional","affiliation":[{"name":"Department VII, Internal Medicine II, Discipline of Cardiology, University of Medicine and Pharmacy \u201cVictor Babes\u201d Timisoara, E. Murgu Square, Nr. 2, 300041 Timisoara, Romania"},{"name":"County Emergency Hospital, 300041 Timisoara, Romania"},{"name":"Center of Molecular Research in Nephrology and Vascular Disease, Faculty of Medicine, University of Medicine and Pharmacy \u201cVictor Babes\u201d Timisoara, E. Murgu Square, Nr. 2, 300041 Timisoara, Romania"},{"name":"County Emergency Hospital \u201cPius Brinzeu\u201d, L. Rebreanu Str., Nr. 156, 300041 Timisoara, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,5,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/MEJ.0000000000000717","article-title":"Collateral Damage of the COVID-19 Outbreak: Expression of Concern","volume":"27","author":"Claret","year":"2020","journal-title":"Eur. J. Emerg. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1056\/NEJMc2010419","article-title":"Clinical Characteristics of Covid-19 in New York City","volume":"382","author":"Goyal","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_3","unstructured":"(2021, January 30). ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic. Available online: https:\/\/www.escardio.org\/Education\/COVID-19-and-Cardiology\/ESC-COVID-19-Guidance."},{"key":"ref_4","first-page":"1","article-title":"Protecting the Most Vulnerable during COVID-19 and beyond: A Case Report on the Remote Management of Heart Failure Patients with Cardiac Implantable Electronic Devices","volume":"4","author":"Ahmed","year":"2020","journal-title":"Eur. Heart J. Case Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41569-020-0409-5","article-title":"Reduced Hospital Admissions for ACS\u2014More Collateral Damage from COVID-19","volume":"17","author":"Huynh","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/jocs.14638","article-title":"Collateral Damage of COVID-19 Pandemic: Delayed Medical Care","volume":"35","author":"Masroor","year":"2020","journal-title":"J. Card. Surg."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1056\/NEJMc2014816","article-title":"Collateral Effect of Covid-19 on Stroke Evaluation in the United States","volume":"383","author":"Kansagra","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e233","DOI":"10.1016\/j.hrthm.2020.03.028","article-title":"Guidance for Cardiac Electrophysiology during the COVID-19 Pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Association","volume":"17","author":"Lakkireddy","year":"2020","journal-title":"Heart Rhythm"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.amjcard.2020.05.029","article-title":"Declines in Acute Cardiovascular Emergencies During the COVID-19 Pandemic","volume":"129","author":"Zaleski","year":"2020","journal-title":"Am. J. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/eurheartj\/ehaa690","article-title":"Corrigendum to: Reduction of Hospitalizations for Myocardial Infarction in Italy in the COVID-19 Era","volume":"42","author":"Spaccarotella","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ijcard.2011.09.049","article-title":"Incidence of New Onset Bundle Branch Block and Atrial Fibrillation in Patients with Type 2 Diabetes and Macrovascular Disease: An Analysis of the PROactive Study","volume":"153","author":"Pfister","year":"2011","journal-title":"Int. J. Cardiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1378\/chest.128.4.2611","article-title":"Increased Prevalence of Third-Degree Atrioventricular Block in Patients With Type II Diabetes Mellitus","volume":"128","author":"Movahed","year":"2005","journal-title":"Chest"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"715","DOI":"10.4103\/ijem.IJEM_448_16","article-title":"Arrhythmias in Type 2 Diabetes Mellitus","volume":"21","author":"Agarwal","year":"2017","journal-title":"Indian J. Endocrinol. Metab."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Dalgaard, F., Ruwald, M.H., Lindhardt, T.B., Gislason, G.H., Torp-Pedersen, C., and Pallisgaard, J.L. (2018). Patients with Atrial Fibrillation and Permanent Pacemaker: Temporal Changes in Patient Characteristics and Pharmacotherapy. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0195175"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"On behalf of the Israeli Working Group of Pacing and EP, Steiner, H., Geist, M., Goldenberg, I., Suleiman, M., Glikson, M., Tenenbaum, A., Swissa, M., Fisman, E.Z., and Golovchiner, G. (2016). Characteristics and Outcomes of Diabetic Patients with an Implantable Cardioverter Defibrillator in a Real World Setting: Results from the Israeli ICD Registry. Cardiovasc. Diabetol., 15, 160.","DOI":"10.1186\/s12933-016-0478-2"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/europace\/euu233","article-title":"Current Use of Implantable Electrical Devices in Sweden: Data from the Swedish Pacemaker and Implantable Cardioverter-Defibrillator Registry","volume":"17","author":"Gadler","year":"2015","journal-title":"Europace"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1586\/14779072.2015.1059276","article-title":"Implantable Cardioverter Defibrillators in Diabetics: Efficacy and Safety in Patients at Risk of Sudden Cardiac Death","volume":"13","author":"Shahreyar","year":"2015","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/joa3.12411","article-title":"Impact of COVID-19 on Pacemaker Implant","volume":"36","year":"2020","journal-title":"J. Arrhythm."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e008722","DOI":"10.1161\/CIRCEP.120.008722","article-title":"Urgent Pacemaker Implantation Rates in the Veneto Region of Italy After the COVID-19 Outbreak","volume":"13","author":"Migliore","year":"2020","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e194176","DOI":"10.1001\/jamanetworkopen.2019.4176","article-title":"Risk Factors Associated With Atrioventricular Block","volume":"2","author":"Kerola","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"ref_21","first-page":"1","article-title":"Diabetic Polyneuropathy in Type 2 Diabetes Mellitus: Inflammation, Oxidative Stress, and Mitochondrial Function","volume":"2016","year":"2016","journal-title":"J. Diabetes Res."},{"key":"ref_22","first-page":"1","article-title":"The Role of Oxidative Stress, Mitochondrial Function, and Autophagy in Diabetic Polyneuropathy","volume":"2017","year":"2017","journal-title":"J. Diabetes Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1093\/europace\/eut032","article-title":"Cardiac Resynchronization Therapy-Defibrillator Improves Long-Term Survival Compared with Cardiac Resynchronization Therapy-Pacemaker in Patients with a Class IA Indication for Cardiac Resynchronization Therapy: Data from the Contak Italian Registry","volume":"15","author":"Morani","year":"2013","journal-title":"Europace"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s11739-020-02487-w","article-title":"Impact of COVID-19 Pandemic on the Clinical Activities Related to Arrhythmias and Electrophysiology in Italy: Results of a Survey Promoted by AIAC (Italian Association of Arrhythmology and Cardiac Pacing)","volume":"15","author":"Boriani","year":"2020","journal-title":"Intern. Emerg. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ajem.2021.01.083","article-title":"Temporal Association of Contamination Obsession on the Prehospital Delay of STEMI during COVID-19 Pandemic","volume":"43","author":"Keskin","year":"2021","journal-title":"Am. J. Emerg. Med."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/5\/441\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:56:57Z","timestamp":1760162217000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/5\/441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,3]]},"references-count":25,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,5]]}},"alternative-id":["medicina57050441"],"URL":"https:\/\/doi.org\/10.3390\/medicina57050441","relation":{},"ISSN":["1648-9144"],"issn-type":[{"type":"electronic","value":"1648-9144"}],"subject":[],"published":{"date-parts":[[2021,5,3]]}}}